News | Radiation Therapy | February 13, 2017

Accuray Radixact System Receives Shonin Approval in Japan

Next-generation “smart” TomoTherapy system offers enhanced treatment speed, ease of use and adaptive therapy capabilities

Accuray, Radixact treatment delivery system, TomoTherapy, Shonin approval, Japan

February 13, 2017 — Accuray Inc. announced that it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its Radixact Treatment Delivery System, Accuray Precision Treatment Planning System and iDMS Data Management System. Together, the treatment delivery system and software solutions enable clinicians to provide efficient, highly precise treatment for a wider range of cancer patients, including those undergoing retreatment. This new Radixact platform is now available in Japan, in certain markets in the European Union, and in the U.S. market.

The Radixact System was designed to be an easy-to-operate, highly reliable, advanced radiation therapy device. The system features a more powerful linear accelerator, low-dose fan beam megavoltage computed tomography (MVCT) imaging and unique helical treatment mode, so that clinicians can deliver highly accurate, individualized dose distributions to any tumor. The fully-integrated, simplified adaptive treatment planning solution enables clinicians to routinely adjust treatment plans during the course of treatment to account for changes in tumor size, shape and location – thereby increasing treatment precision.

For more information: www.accuray.com/radixact

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more